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In order to distinguish the disorder of bile acid and cholesterol metabolism in _-naphthyl-
isothiocyanate (ANIT)-induced cholestasis, we examined changes in bile acid levels and
compositions in bile, serum, feces and urine, as well as cholesterol levels in bile, serum,
liver and feces in Wistar male rats (10–13 weeks) after a single oral administration of
100 mg/kg of ANIT.  The bile flow and the biliary secretions of cholesterol, phospholipids
and bile acids markedly decreased on days 1 and 2 but increased over the normal values
on day 4 and then returned to the normal ranges.  The fecal excretion of bile acids
decreased after the treatment and remained low by day 4 but markedly increased
thereafter.  The urinary excretion of bile acids changed almost in parallel with serum
bile acid level, increasing to 37 mg/day on day 2, 28 mg/day on days 3–4 but to a trace
on days 5–6.  The urinary bile acids on day 2 mainly consisted of cholic acid while those
on days 3–4 and biliary bile acids on day 4 were mostly `-muricholic acid.  The serum
cholesterol level markedly increased maximally on day 2 and decreased thereafter.  The
fecal excretion of sterols, cholesterol and coprostanol, decreased on days 1–2 but rather
increased thereafter.  These data suggest that the cholestasis induced by ANIT is very
similar to that in bile duct ligated rats for a short period but not to those ligated for
long periods.  In addition, the present data suggest that the bile acid independent bile
flow is impaired and the daily synthesis of bile acids, especially `-muricholic acid, is
increased in the ANIT induced cholestasis.
Key words:  bile secretion; biliary lipids; fecal bile acids and sterols; _-naphthylisothiocyanate;
serum lipids; urinary bile acids
Abbreviations:  ANIT, _-naphthylisothiocyanate; bsep, bile salt export pump; GLC, gas-liquid chromatogra-
phy; mdr2, multidrug resistance 2; mrp2, multidrug resistance associated protein 2
_-Naphthylisothiocyanate (ANIT) is a com-
pound which causes cholestasis, hepatocellular
and biliary epithelial cell necrosis, bile duct ob-
struction and biliary epithelial cell hyperplasia
in rats (Plaa and Priestly, 1976).  The changes in
biliary epithelial cells are reported to be com-
parable to that induced by bile duct ligation
(Kossor et al., 1995).
Previously, we examined the changes in bile
acid metabolism after bile duct ligation in rats
(Kinugasa et al., 1981, Takita et al., 1988) and
those after the release of bile duct ligation
(Fujio et al., 1989).  A striking change in bile
duct ligated rats was a marked increase in `-
muricholic acid with a concomitant decrease of
cholic acid.  The change was normalized within
a week after the release of ligation regardless of
the duration of ligation, but the changes in bile
flow and biliary bile acid secretion were differ-
ent according to the duration.  Release after a 1-
week ligation showed a temporal rebound in-
crease in both bile flow and biliary bile acid se-
cretion, but release after a 2-week ligation
caused a continuous hypersecretion of the bile
without any rebound increase in biliary bile
acid secretion (Fujio et al., 1989).
In the present experiments, we examined the
changes in bile flow and bile acid metabolism
after ANIT administration until cholestasis was
completely recovered in rats.
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portion of the largest lobe of the liver ( lobus si-
nistra externa) was homogenized with 9 vol-
umes of water.  The serum and the liver homog-
enate were extracted in 9 volumes of ethanol by
refluxing for 20 min at 90–95˚C.  Total choles-
terol was determined with portions of the serum
and liver lipid extracts as previously reported
(Uchida et al., 1965).  Phospholipids were de-
termined by the method of Gomori (1942).
Biliary lipid determination
The bile was added to 20 volumes of ethanol,
brought to boil once for several minutes, cooled
down to room temperature, and then filtered.
An aliquot of the filtrate was evaporated to
dryness under a mild stream of nitrogen and the
residue was hydrolyzed at 120˚C for 6 h in 1.25
M sodium hydroxide solution.  Sterols were ex-
tracted with diethyl ether, the reaction mixture
was acidified with 2 M hydrochloric acid and
then the bile acids were extracted with diethyl
ether.  The bile acids were methylated with
freshly prepared diazomethane and then tri-
fluoroacetylated with trifluoroacetic anhydride.
The bile acid derivatives were quantified by
gas-liquid chromatography (GLC) with a 1%
QF-1 column and cholesterol with a 1% SE-30
column (Uchida et al., 1970, 1977).  Biliary phos-
pholipids were determined by the methods of
Gomori (1942).
Urinary and serum bile acid determina-
tion
The urine was applied to an Amberlite XAD-2
column and bile acids were eluted with meth-
anol according to the method of Makino et al.
(1974).  The eluate was evaporated to dryness and
the residue was dissolved in 30 mL of acetone-
ethanol (9:1) containing 0.01 volume of 2 M hy-
drochloric acid.  The solution was left at room
temperature for 2 to 3 days to complete solvolysis.
The reaction mixture was then evaporated to dry-
ness and the residue was subjected to alkaline
hydrolysis.  After extraction with diethyl ether, the
bile acids were methylated and trifluoroacetylat-
ed, and analyzed by GLC as mentioned above.
Serum bile acids were isolated by the use of
an Amberlyst A-26 column (Sandberg et al.,
Materials and Methods
ANIT obtained from Nakarai Pure-Chemicals
(Tokyo, Japan) was dissolved in corn oil at a con-
centration of 100 mg/mL, and a single dose of
ANIT (100 mg/kg) was administered orally to
rats.  This dosage was selected based on the re-
port of Kossor et al. (1995) who examined the
effect of various doses of ANIT (25–150 mg/kg)
in rats and showed that a dose of 100 mg/kg induc-
ed a modest cholestasis at 48 h after treatment.
Control rats received 1 mL/kg of corn oil orally.
Animal treatments
Wistar strain male rats weighing about 300 g
(10–13 weeks old) were kept in an air-condi-
tioned room (25 ± 1˚C, 50–60% humidity)
lighted 12 h a day (8:00–20:00) and maintained
on a commercial stock diet ( Japan CLEA CA-1,
Tokyo, Japan).
In the first experiment, rats were individual-
ly caged and daily urine specimens were col-
lected for 10 days after the administration of
ANIT.  Daily urine volume, diet intake and wa-
ter intake were recorded.  In the second experi-
ment, rats were individually caged and sacrific-
ed 2, 4, 6, 8 and 10 days after the administration
of ANIT to collect bile, blood and liver speci-
mens.  Two-day feces specimens were collect-
ed prior to sacrifice as described previously
(Uchida et al., 1977).  On the day of sacrifice,
the rats were cannulated of their bile duct with
PE-10 polyethylene tubings in order to collect
the bile for 30 min under sodium pentobarbital
anesthesia (50 mg/kg, intraperitoneally).  Dur-
ing the time of bile collection, the rectal temper-
ature was maintained at 36–37˚C using an elec-
tric warm plate.  The blood was then withdrawn
by heart puncture and the liver was removed for
lipid determination.  Bile was collected be-
tween 9:00–11:00 to avoid any variation due to
the circadian rhythm.
Serum and liver lipid determination
The serum was separated by centrifugation at
3,000 rpm for 15 min after allowing the blood to
stand for at least 30 min at room temperature.  A
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1965) and quantified by GLC after alkaline hy-
drolysis without any procedure for solvolysis.
Fecal sterol and bile acid determination
The feces were dried and powdered, according
to the procedures described previously (Uchida
et al., 1977).  An aliquot of the pulverized feces
was extracted with 20 volumes of boiling etha-
nol for 1 h and filtered after cooling down to
room temperature.  The extraction procedures
were repeated three times.  The combined fil-
trate was evaporated to dryness under reduced
pressure, and the residue was hydrolyzed at
120˚C for 6 h in 1.25 M sodium hydroxide solu-
tion.  Sterols were extracted with diethyl ether,
the reaction mixture was acidified with 2 M
hydrochloric acid and then bile acids were ex-
tracted with diethyl ether.  The methylated and
trifluoroacetylated bile acids were quantified by
GLC with a 1% QF-1 column and sterols with a
1% SE-30 column (Uchida et al., 1977; Kinugasa
et al., 1981).  The extraction efficiency of sterols
and bile acids from feces was over 92.5%
(Kinugasa et al., 1981).
Statistical analysis
Data are expressed as mean ± SE.  The difference
between the means of variables was calculated
Table 1.  Changes in body weight, diet intake and water intake after _-naphthylisothiocyanate
(ANIT) administration in rats
Days after ANIT administration
0 1 2 4 6 8 10
Body weight (g) 338 ± 3.2 315 ± 3.8* 304 ± 2.3* 312 ± 1.5* 318 ± 5.2 332 ± 4.1 342 ± 2.7
Diet intake (g/day)   22 ± 1.0     5 ± 0.8*     3 ± 1.3*   14 ± 2.7*   22 ± 1.0   26 ± 1.4 —
Water intake (mL/day)   30 ± 4.5     5 ± 1.6*   18 ± 4.4   33 ± 2.8   34 ± 5.3   39 ± 3.5 —
Mean ± SE in 5 rats.
—, not determined.
* Statistically significant compared with day 0 (P < 0.05).
Table 2.  Changes in urinary bile acids after _-naphthylisothiocyanate (ANIT) administration in rats
                                                                                         Days after ANIT administration
0 1 2   3–4‡   5–6‡   7–8‡   9–10‡
Urine volume (mL/day)    12 ± 1.8    15 ± 1.2*      11 ± 2.0      15 ± 3.3    18 ± 2.2    19 ± 2.1*    20 ± 2.1*
Urinary bile acids 0.01 ± 0.00 2.01 ± 0.56* 37.29 ± 3.74* 28.07 ± 3.10* 0.09 ± 0.01* 0.07 ± 0.01* 0.05 ± 0.01*
(mg/day)
Bile acid composition (%)
   Lithocholic acid    31 ± 4.7        < 1          < 1         < 1    17 ± 5.0      6 ± 0.8*    11 ± 3.3*
   Chenodeoxycholic acid   3 ± 2.2        < 1        1 ± 0.0        2 ± 0.5        < 1        ND        ND
   _-Muricholic acid      2 ± 1.7      3 ± 0.4        1 ± 0.1        3 ± 0.2      2 ± 0.6      3 ± 1.0      3 ± 1.2
  `-Muricholic acid      4 ± 0.6    16 ± 5.8      16 ± 1.1*      46 ± 3.4*    16 ± 2.4*      7 ± 2.0      9 ± 2.5
   t-Muricholic acid      8 ± 0.6      3 ± 0.4        3 ± 0.2        3 ± 0.9      7 ± 0.8      4 ± 0.8      7 ± 0.7
   Ursodeoxycholic acid      1 ± 0.8        < 1          < 1        3 ± 0.6        < 1        ND        ND
   Hyodeoxycholic acid        < 1        < 1          < 1        1 ± 0.3        ND        ND        ND
   Deoxycholic acid        ND        < 1          < 1          < 1        < 1        ND        < 1
   Cholic acid    47 ± 6.4    55 ± 7.0      62 ± 0.9      31 ± 2.5    42 ± 7.6    73 ± 1.9    63 ± 6.6
   Peak 8†        ND    15 ± 5.4        9 ± 0.8        7 ± 0.8      3 ± 1.2      4 ± 0.8      4 ± 1.2
   Others      3 ± 1.0      6 ± 0.6        6 ± 0.2        4 ± 0.3    13 ± 3.3        < 1      4 ± 0.7
Mean ± SE in 5 rats.
ND, not detectable.
† Unidentified.
‡ Samples of 2-day urine specimens were combined.
* Statistically significant compared with day 0 (P < 0.05).
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by Student’s t-test.  Values of P < 0.05 were con-
sidered to be statistically significant.
Results
As shown in Table 1, the body weight decreased
and showed the lowest value on day 2 after ANIT
administration and recovered gradually there-
after.  Diet and water intake decreased marked-
ly on the first day but diet intake recovered to
the initial level by day 6 and the water intake by
day 4.
Urine volume increased on day 1, returned
to the initial level on day 2, and slightly increas-
ed thereafter.  The urinary excretion of bile
acids markedly increased on day 2 and probably
on day 3, and then rapidly decreased.  The ma-
jor component in urinary bile acids was cholic
acid in the control rats, but `-muricholic acid
increased after ANIT administration and be-
came the major component on days 3–4.  Cholic
acid rather decreased on days 3–4, but gradually
increased thereafter in accordance with the de-
crease of `-muricholic acid (Table 2).
The changes in the feces dry weight, and
fecal sterol and bile acid excretions are shown
in Table 3.  The feces dry weight decreased on
days 1–2 but was restored after days 5–6.  The
fecal sterol excretion decreased once on days 1–
2, but markedly increased on days 3–4 and then
gradually decreased.  The composition ratios of
coprostanol and cholesterol were almost identi-
cal in all the groups.  The fecal bile acid excre-
tion decreased after ANIT administration to the
lowest level on days 3–4, but in turn markedly
increased on days 5–6 attaining almost twice
the level of the control rats, and gradually de-
clined thereafter.  Deoxycholic acid comprised
about 25% in the control rats but decreased on
days 3–4 and 5–6, and was then restored to the
initial level.  Instead, `-muricholic acid and t-
muricholic acid increased while deoxycholic
acid decreased.  Hyodeoxycholic acid decreas-
ed after days 3–4, and remained low thereafter,
while t-muricholic acid increased and kept
high levels after days 5–6.
Table 4 shows the changes in the bile flow
and biliary lipid secretions after ANIT adminis-
tration.  The bile flow markedly decreased, al-
most to 1/10 that of the initial level, on days 1
and 2, but increased showing higher levels than
the initial level on days 4 and 10.  Biliary bile
acid secretion also decreased on days 1 and 2,
increased on day 4 and was restored to the con-
trol level after day 6.  The biliary cholesterol
Table 3.  Changes in feces dry weight and fecal sterols and bile acids after _-naphthylisothio-
cyanate (ANIT) administration in rats
      Days after ANIT administration
0 1–2 3–4 5–6 7–8 9–10
Feces dry weight (g/day)    4.5 ± 0.39   1.3 ± 0.18*     3.6 ± 0.53     4.6 ± 0.22     5.4 ± 0.27     5.7 ± 0.16
Fecal total sterols (mg/day)  7.49 ± 0.71 1.98 ± 0.27* 13.98 ± 2.58* 12.72 ± 1.22* 11.24 ± 0.42*     9.78 ± 1.06
Sterol composition (%)
   Coprostanol     54 ± 5.8    46 ± 7.7      57 ± 9.4      50 ± 7.7      50 ± 6.3      56 ± 7.0
   Cholesterol     47 ± 4.5    54 ± 11.0      43 ± 9.2      50 ± 11.0      50 ± 2.7      44 ± 5.1
Fecal bile acids (mg/day)  8.17 ± 0.68 2.56 ± 0.34*   1.61 ± 0.25* 14.73 ± 1.28* 12.98 ± 1.47* 11.26 ± 0.69*
Bile acid composition (%)
   Lithocholic acid     10 ± 0.5      7 ± 1.0      26 ± 3.0*        7 ± 1.7        7 ± 1.0        7 ± 0.7
  `-Muricholic acid       6 ± 0.6    15 ± 5.9      13 ± 1.4*      16 ± 3.2*      10 ± 1.9        8 ± 1.3
  t-Muricholic acid     29 ± 5.2    20 ± 2.0      18 ± 3.8      49 ± 5.3*      47 ± 3.3*      46 ± 4.2*
   Hyodeoxycholic acid     22 ± 5.5    22 ± 5.3        7 ± 2.6*        2 ± 0.4*        4 ± 1.2*        6 ± 1.9*
   Deoxycholic acid     26 ± 1.4    28 ± 2.6      18 ± 1.2*      17 ± 1.4*      24 ± 1.5      26 ± 0.7
   Peak 8† and others       8 ± 0.4      9 ± 1.5      18 ± 1.2*      10 ± 1.3        9 ± 0.8        7 ± 0.6
Mean ± SE in 5 rats.
† Unidentified.
* Statistically significant compared with day 0 (P < 0.05).
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and phospholipid secretions changed almost in
parallel with the bile acid secretion.
Striking changes in the biliary bile acid com-
position were an increase of ` -muricholic acid and
a concomitant decrease of cholic acid on days 2
and 4.  The compositions of the other bile acids
were not changed significantly (Table 5).
As shown in Table 6, the serum bile acid
concentration markedly increased on day 1 and
maximally on day 2 (about 30-fold) but abrupt-
ly declined on day 4 almost attaining the control
level.  A decrease in cholic acid and an increase
in `-muricholic acid were also noted on days 2
and 4.  Chenodeoxycholic acid showed high
values on day 0 and day 4, but the reason for
this large variation was not clear.  Such a high
value for chenodeoxycholic acid was detected
neither in the urine, feces nor bile.
The correlations between biliary bile acid
secretion and bile flow, biliary bile acid secre-
tion and biliary cholesterol secretion, and bili-
ary bile acid secretion and biliary phospholipid
secretion are shown in Fig. 1.  As shown in Fig.
1A, a linear regression line was obtained be-
tween the bile acid secretion and bile flow in the
region where the bile acid secretion was over 10
mg/h, by which the bile acid dependent bile
flow was calculated to be 0.018 mL/mg and the
bile acid independent bile flow to be 1.25 mL/h.
However, in the region where the bile acid se-
cretion was less than 10 mg/h, the spots were
under the regression line.
On the contrary, the cholesterol and phos-
pholipid secretions were linearly related to the
bile acid secretion in all regions.  It was calcu-
lated from these relationships that the choles-
terol/bile acids ratio in the bile was 0.012 and
the phospholipids/bile acids ratio was 0.27 on a
Table 5.  Changes in biliary bile acid composition after _-naphthylisothiocyanate (ANIT) admini-
stration in rats
 Composition         Days after ANIT administration
       (%) 0 1 2 4 6 10
Lithocholic acid   1 ± 0.1      < 1      <1   1 ± 0.0      < 1      < 1
Chenodeoxycholic acid   3 ± 0.8   1 ±  0.4   1 ± 0.2*   5 ± 0.9   2 ± 0.2   3 ± 0.5
_-Muricholic acid   3 ± 0.5   2 ±  0.6   2 ± 0.1   4 ± 0.5   3 ± 0.4   3 ± 0.3
`-Muricholic acid 24 ± 4.5 25 ± 10.3 48 ± 7.3* 42 ± 5.3* 27 ± 7.0 22 ± 4.6
t-Muricholic acid   1 ± 0.1   2 ±  0.2   1 ± 0.1      < 1   1 ± 0.1   1 ± 0.2
Hyodeoxycholic acid   2 ± 0.4   4 ±  0.7   1 ± 0.2   1 ± 0.2   1 ± 0.4   2 ± 0.4
Deoxycholic acid   2 ± 0.1   1 ±  0.1*   1 ± 0.1*   1 ± 0.3*   3 ± 0.3   4 ± 0.3*
Cholic acid 41 ± 0.8 38 ±  9.6 31 ± 6.8 21 ± 1.6* 42 ± 4.4 45 ± 2.1
Peak 8† 14 ± 2.4 16 ±  2.1  9  ± 1.5 16 ± 4.3 13 ± 3.7 13 ± 2.7
Others   9 ± 0.6 12 ±  0.9*  8  ± 0.7   9 ± 1.4   8 ± 1.6   8 ± 1.0
Mean ± SE in 5 rats.
† Unidentified.
* Statistically significant compared with day 0 (P < 0.05).
Table 4.  Changes in bile flow and biliary lipid secretions after _-naphthylisothiocyanate (ANIT)
administration in rats
        Days after ANIT administration
0 1 2 4 6 10
Bile flow (mL/h)   1.43 ± 0.02 0.12 ± 0.02* 0.12 ± 0.04*   1.83 ± 0.11*   1.23 ± 0.17   1.60 ± 0.05*
Total cholesterol (mg/h)   0.20 ± 0.01 0.05 ± 0.00 0.05 ± 0.00   0.43 ± 0.05*   0.18 ± 0.03   0.19 ± 0.01
Phospholipids (mg/h)   5.03 ± 0.39 0.27 ± 0.07* 0.24 ± 0.06* 20.22 ± 3.74*   6.74 ± 0.90   7.53 ± 0.81*
Bile acids (mg/h) 12.90 ± 0.82 0.37 ± 0.26* 0.52 ± 0.16* 34.49 ± 5.32* 12.61 ± 1.37 16.72 ± 1.49
Mean ± SE in 5 rats.
* Statistically significant compared with day 0 (P < 0.05).
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molar basis.  Therefore, the molar ratio of cho-
lesterol and phospholipids in the bile was about
1:22.
The changes in the serum and liver lipid
levels are given in Table 7.  The serum choles-
terol and phospholipid levels significantly in-
creased on day 1 and further increased on day 2,
but gradually decreased thereafter and return-
ed to control levels on day 10.  The cholesterol/
phospholipids ratio remained almost constant
but rather increased after day 4.  The serum tri-
glyceride level slightly decreased after ANIT
administration.  The liver weight per 100 g body
weight rather increased after day 2, reflecting
decreases in body weight.  The liver cholesterol
level slightly increased after ANIT treatment
but the phospholipid levels remained unchang-
ed.  The liver triglyceride level decreased on
day 2 but only slightly on days 6 and 10.
Discussion
The present experiments not only demonstrated
that ANIT caused cholestasis in rats, but also
clarified the changes in cholesterol and bile acid
levels in the bile, serum, liver, urine and feces in
relation to cholestasis.  The bile flow was in-
hibited, less than 10% of the control, for at least
2 days after a single oral administration of 100
mg/kg of ANIT, but showed  hypersecretion on
day 4 and then returned to the control level.
The biliary secretions of bile acids, cholesterol
and phospholipids changed almost in parallel
with the bile flow.  These changes are almost
consistent with previous reports (Maeyama,
1977, Fukumoto et al., 1980, Lock et al., 1982).
In the previous experiment, we examined
changes in bile flow and biliary bile acid secre-
tion after release of the bile duct ligation in rats
(Fujio et al., 1989).  The release after a short
period of obstruction restored normal bile flow
but release after a long period of obstruction did
not.  When the ligation was released by 1 week,
bile flow and biliary bile acid secretion increas-
ed once over the control levels and were then
restored to the normal ranges.  When the liga-
tion was released after 2 weeks, the bile flow
markedly increased and remained high there-
after, while the biliary bile acid secretion gradu-
ally increased to the normal range.  The present
data in the ANIT treated rats coincide with the
pattern observed after a short period ligation.
As shown in Fig. 1A, the spots in the region
where the bile acid secretion was less than 10
mg/h were under the regression line.  The bile
acid dependent bile flow is provided by the bili-
ary bile acid composition and is increased by
non-micellar bile acids such as oxo-bile acids
(Loria et al., 1989).  ANIT treatment caused
changes in bile acid composition, an increase of
`-muricholic acid with a concomitant decrease
of cholic acid, but showed no remarkable in-
crease of oxo-bile acids (Table 5).  Therefore, it
Table 6.  Changes in serum bile acids after _-naphthylisothiocyanate (ANIT) administration in rats
        Days after ANIT administration
0 1 2 4 6 10
Bile acids             (μg/mL)   4.4 64.4 124.0   6.6   5.2   3.8
Composition                (%)
   Lithocholic acid   ND   ND     ND   ND   ND   ND
   Chenodeoxycholic acid 16.9   1.4     4.4 18.5   6.0   6.1
_-Muricholic acid   ND   0.7     1.4   5.0   1.5   1.6
`-Muricholic acid   —   6.0   56.9 20.5   5.0    —
   Hyodeoxycholic acid   2.1   4.6     0.7   1.9   2.4   8.6
   Peak 8†   1.4   1.8     0.5   ND   0.9   ND
   Cholic acid 72.2 75.7   31.7 45.1 69.3 68.2
   Deoxycholic acid   2.5   2.1     0.1   1.7   4.2   4.1
   Others   5.0   7.6     4.2   7.4 10.8 11.4
Samples of 5 rats were combined before analysis.
—, included in cholic acid.
ND, not detectable.
† Unidentified.
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Fig. 1.  Correlations between biliary bile acid secretion and bile flow (A), biliary bile acid secretion and
biliary cholesterol secretion (B) and biliary bile acid secretion and biliary phospholipid secretion (C) in
controls and ANIT treated rats.  Broken lines in (A) are given under the assumption that the bile acid
dependent bile flow is not changed by ANIT (see text).
is assumed that bile acid dependent bile flow is
not influenced by ANIT.  Based on this assum-
ption, dots representing the bile acid secretion
in the region less than 10 mg/h are considered to
be on the regression lines shown by broken
lines having the same slope with the solid line.
Fukumoto et al. (1980) and Lock et al. (1982)
reported that the bile acid independent bile flow
was inhibited in ANIT treated rats from a study
measuring the biliary clearance of erythritol.
This conclusion was consistent with the present
data (Fig. 1A).  Furthermore, the bile flow in
ANIT treated rats markedly increased on day 4,
but this increase was due to the bile acid depen-
dent bile flow, because the plots for day 4 were
completely matched with the regression line be-
tween biliary bile acid secretion and bile flow
(Fig. 1A).  On the other hand, the cholesterol
and phospholipid secretions were linearly relat-
ed to the bile acid secretion closing the origin
(Figs. 1B and C), and the molar ratio of choles-
terol and phospholipid in the bile was 1:22.
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This value is not consistent with the cholesterol
and phospholipid ratio in the liver membrane of
rats (Daum, 1985).
Biliary bile acid excretion is under the regu-
lation of transporters, the bile salt export pump
(bsep) (Gerloff et al., 1998) and multidrug re-
sistance associated protein 2 (mrp2) (Paulusma
et al., 1996), in the canalicular membrane of the
hepatocyte.  Bsep is concerned with the excre-
tion of amino acid conjugated bile acids and
mrp2 with the excretion of bile acid sulfates and
glucuronides.  Biliary cholesterol and phospho-
lipid secretions are related to multidrug resist-
ance 2 (mdr2) P-glycoprotein.  Phospholipid se-
cretion is completely, and the cholesterol secre-
tion is partially, dependent on mdr2 gene ex-
pression (Oude Elferink et al., 1996).
Cholestasis induced by lipopolysaccharide
(Kubitz et al., 1999; Lee et al., 2000), phalloidin
(Rost et al., 1999), ethinylestradiol (Lee et al.,
2000), or bile duct ligation (Lee et al., 2000;
Paulusma et al., 2000) is accompanied by changes
in bsep and/or mrp2.  ANIT produced cholestasis
and decreased biliary cholesterol and phospho-
lipid secretion in parallel with the bile acid se-
cretion (Figs. 1B and C), but ANIT is reported to
have no effect on mrp2 (Ogawa et al., 2000).  The
effect of ANIT on bsep is not yet known.
`-Muricholic acid in the biliary bile aids in-
creased especially on day 4, the day when the
biliary bile acid secretion markedly increased,
with a concomitant decrease in cholic acid.
These changes, however, were normalized on
day 6 or later.  Maeyama (1977) also reported
an increase of `-muricholic acid in ANIT treat-
ed rats even after the bile flow was recovered.
The increase of `-muricholic acid and a de-
crease of cholic acid were also found in the se-
rum, urine and feces.  In the feces, the increase
of `-muricholic acid was found as the increase
of t-muricholic acid formed from `-muricholic
acid by the action of intestinal bacteria.
The increase of `-muricholic acid is also re-
ported in bile duct ligated rats (Kinugasa et al.,
1981; Takita et al., 1988; Fujio et al., 1989), in-
dicating that cholestasis causes an increase in `-
muricholic acid formation.  Takita et al. (1988)
suggested that an alternative metabolic pathway
in bile acid synthesis via 26-hydroxycholesterol,
3`-hydroxy-5-cholenoic acid and lithocholic
acid contributes to the increase of `-muricholic
acid in bile duct ligated rats.  `-Muricholic acid
formation is known to increase after the feeding
of cholesterol in rats (Uchida et al., 1977), which
results in an elevation of the liver cholesterol
level.  In the case of ANIT treatment (the pres-
ent experiment) and bile duct ligation (Kinugasa
et al., 1981), a minor or no increase in the liver
cholesterol level was found, though significant
hypercholesterolemia was produced.  The mecha-
nism for this increase of `-muricholic acid in
cholestasis is not yet known.
Table 7.  Changes in serum and liver lipid levels after _-naphthylisothiocyanate (ANIT) administra-
tion in rats
        Days after ANIT administration
0 1 2 4 6 10
Body weight (g)  328 ± 3.5  311 ± 3.3*  302 ± 4.9*  309 ± 4.9*  304 ± 4.2*   309 ± 4.9*
Serum total cholesterol    67 ± 1.7  147 ± 10.1*  204 ± 20.0*  170 ± 6.9*    84 ± 3.3*     75 ± 3.5
(mg/dL)
   Phospholipids (mg/dL)  134 ± 1.4  305 ± 26.3*  375 ± 46.3*  257 ± 13.8  150 ± 11.3   135 ± 3.7
   Triglyceride (mg/dL)    84 ± 5.0    71 ± 3.0*    63 ± 4.6*    63 ± 3.5*    63 ± 4.0*     60 ± 2.2*
   C/P ratio 0.50 ± 0.017 0.48 ± 0.014 0.55 ± 0.019 0.66 ± 0.024* 0.56 ± 0.020  0.56 ± 0.014*
Liver weight   
3.8 ± 0.10   3.7 ± 0.06   4.1 ± 0.06*   4.6 ± 0.07*   4.2 ± 0.09*    4.0 ± 0.08(g/100g body weight)
   Total cholesterol(mg/g)   3.3 ± 0.07   3.5 ± 0.16   3.8 ± 0.09*   3.7 ± 0.08*   3.5 ± 0.07*     3.5 ± 0.03*
   Phospholipids (mg/g) 46.9 ± 0.83 49.1 ± 0.67 46.1 ± 1.17 45.3 ± 0.79 45.5 ± 1.13  45.0 ± 0.69
   Triglyceride (mg/g)   3.7 ± 0.18   4.7 ± 0.56   2.9 ± 0.28*  4. 3 ± 0.17   3.1 ± 0.16*     3.0 ± 0.16*
Mean ± SE in 5 rats.
C/P, cholesterol/phospholipids.
* Statistically significant compared with day 0 (P < 0.05).
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The serum bile acid concentration markedly
increased after ANIT treatment and the urinary
bile acid excretion increased being delayed
about 1 day more than the increase of the serum
bile acids.  The enormous amounts of urinary
bile acids on day 2 came, we expect, from the
bile acid pool in the enterohepatic circulation.
Fecal bile acid excretion decreased during
cholestasis, but increased after day 5 or later
exceeding the initial level.  This increase is a
reflection of the increase of the bile acid synthe-
sis in the liver.  Hepatic cholesterol synthesis
and cholesterol 7_-hydroxylation activities are
reported to increase in bile duct ligated rats
(Danielsson, 1973; Cooper and Ockner, 1974;
Adler et al., 1977).  When one lobe of the liver
was experimentally ligated, cholesterol synthe-
sis increased only in the ligated lobe (Cooper
and Ockner, 1974; Adler et al., 1977).  There-
fore, cholestasis is considered to increase hepat-
ic cholesterol synthesis, and probably subse-
quent bile acid synthesis, in rats.
Fecal sterol excretion decreased on days 1–
2 reflecting a decrease in feces dry weight, but
markedly increased on days 3–4 and then grad-
ually decreased to the initial level.  The compo-
sition ratios of coprostanol and cholesterol were
almost identical through out the experimental
period, suggesting that the intestinal bacteria
concerned with the sterol transformation were
not changed by ANIT treatment.  On the other
hand, the secondary bile acid composition was
changed after ANIT treatment.  t-Muricholic
acid increased and hyodeoxycholic acid de-
creased after days 5–6 or later.  `-Muricholic
acid is transformed to t-muricholic acid and
then to hyodeoxycholic acid by the intestinal
bacteria.  Therefore, the intestinal bacteria con-
cerned with the bile acid metabolism were
changed in the ANIT treated rats.
The serum cholesterol and phospholipid
levels increased for 4 to 5 days after ANIT
treatment.  Since enhancement of cholesterol
absorption is not the reason, the increase may
be a reflection of biliary epithelial cell necrosis
(Orsler et al., 1999).
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